The newly reported Omicron variant is poised to replace Delta as the most prevalent severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant across the world. Cryo–…

Mutations in the spike glycoproteins of SARS-CoV-2 variants of concern have independently
been shown to enhance aspects of spike protein fitness. Here, we describe an antibody …

The recently reported “UK variant” (B.1.1.7) of SARS-CoV-2 is thought to be more infectious
than previously circulating strains as a result of several changes, including the N501Y …

Transmembrane protease, serine 2 (TMPRSS2) has been identified as key host cell factor
for viral entry and pathogenesis of SARS-CoV-2. Specifically, TMPRSS2 proteolytically …

The recently emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Beta (B.1.351) and Gamma (P.1) variants of concern (VoCs) include a key mutation (N501Y) …

The Delta and Kappa variants of SARS-CoV-2 co-emerged in India in late 2020, with the
Delta variant underlying the resurgence of COVID-19, even in countries with high vaccination …

The SARS-CoV-2 spike glycoprotein is a focal point for vaccine immunogen and therapeutic
antibody design, and also serves as a critical antigen in the evaluation of immune …

The BA.2 sub-lineage of the Omicron (B.1.1.529) severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variant rapidly supplanted the original BA.1 sub-lineage in early 2022. …

AAA ATPases are a conserved group of enzymes that couple ATP hydrolysis to diverse
activities critical for cellular homeostasis by targeted protein–protein interactions. Some of these …

Novel COVID-19 therapeutics are urgently needed. We generated a phage-displayed
human antibody V H domain library from which we identified a high-affinity V H binder ab8. …